• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

默克尔细胞癌:手术与放射治疗联合应用

Merkel cell carcinoma: combined surgery and radiation therapy.

作者信息

Cotlar A M, Gates J O, Gibbs F A

出版信息

Am Surg. 1986 Mar;52(3):159-64.

PMID:3954263
Abstract

Merkel cell carcinoma, first reported as "trabecular carcinoma" by Toker in 1972, is a dangerous, often fatal primary skin tumor. The current authors report eight patients, only one of whom is considered to have a totally successful clinical outcome. Two patients died and one was preterminal with widespread disease in 10 to 20 months. Two others had recurrence or metastases within a year, and two patients died early of intercurrent disease after first developing regional lymph node involvement. Review of 139 patients reported in the literature indicates local recurrence in 30 per cent, regional lymph node metastases in 50 per cent, and death from neoplasm in 18 per of the cases. All patients in the present series received radiation therapy with encouraging response. The tumor was quite radiosensitive, and in only one instance was there recurrence within an irradiated field. Wide surgical excision with prompt postoperative irradiation to the local site and regional lymphatics is the therapy of choice in early lesions. Regional lymphadenectomy is recommended whenever nodal involvement is suspected. Currently, an aggressive combined surgical and radio-therapeutic approach to this dangerous neoplasm appears warranted, although further data may show that early and routine use of radiotherapy in Merkel cell carcinoma could obviate the necessity for extensive operative procedures.

摘要

默克尔细胞癌于1972年由托克尔首次报告为“小梁癌”,是一种危险的、通常致命的原发性皮肤肿瘤。本文作者报告了8例患者,其中只有1例被认为临床结局完全成功。2例患者死亡,1例在10至20个月时处于疾病广泛播散的临终前状态。另外2例在1年内出现复发或转移,2例患者在首次出现区域淋巴结受累后因并发疾病早期死亡。对文献报道的139例患者的回顾表明,30%的病例出现局部复发,50%的病例出现区域淋巴结转移,18%的病例死于肿瘤。本系列所有患者均接受放射治疗,反应令人鼓舞。该肿瘤对放疗相当敏感,仅1例在放疗野内复发。早期病变的治疗选择是广泛手术切除并术后立即对局部和区域淋巴管进行放疗。只要怀疑有淋巴结受累,就建议进行区域淋巴结清扫术。目前,对这种危险的肿瘤采取积极的手术和放射治疗联合方法似乎是必要的,尽管进一步的数据可能表明,在默克尔细胞癌中早期和常规使用放疗可以避免进行广泛手术的必要性。

相似文献

1
Merkel cell carcinoma: combined surgery and radiation therapy.默克尔细胞癌:手术与放射治疗联合应用
Am Surg. 1986 Mar;52(3):159-64.
2
[Significance of sentinel lymph node biopsy in Merkel cell carcinoma. Analysis of 11 cases].[前哨淋巴结活检在默克尔细胞癌中的意义。11例病例分析]
Ann Dermatol Venereol. 2003 Apr;130(4):417-22.
3
Merkel cell carcinoma: report of 10 cases and review of the literature.默克尔细胞癌:10例报告及文献复习
J Am Acad Dermatol. 2000 Nov;43(5 Pt 1):755-67. doi: 10.1067/mjd.2000.106505.
4
Merkel cell carcinoma: assessing the effect of wide local excision, lymph node dissection, and radiotherapy on recurrence and survival in early-stage disease--results from a review of 82 consecutive cases diagnosed between 1992 and 2004.默克尔细胞癌:评估广泛局部切除、淋巴结清扫和放疗对早期疾病复发及生存的影响——对1992年至2004年间连续诊断的82例病例的回顾结果
Ann Surg Oncol. 2007 Jun;14(6):1943-52. doi: 10.1245/s10434-006-9327-y. Epub 2007 Mar 14.
5
[Neuroendocrine primary cutaneous carcinoma. Therapeutic aspects in 13 patients].
Ann Dermatol Venereol. 1996;123(8):443-6.
6
[Merkel cell carcinoma].
Ugeskr Laeger. 1993 Feb 22;155(8):549-52.
7
Adjuvant local irradiation for Merkel cell carcinoma.默克尔细胞癌的辅助局部放疗。
Arch Dermatol. 2006 Jun;142(6):693-700. doi: 10.1001/archderm.142.6.693.
8
Merkel cell carcinoma: improved outcome with adjuvant radiotherapy.默克尔细胞癌:辅助放疗改善预后。
ANZ J Surg. 2005 May;75(5):275-81. doi: 10.1111/j.1445-2197.2005.03353.x.
9
Merkel cell carcinoma: management of primary, recurrent and metastatic disease. A clinicopathological study of 17 patients.默克尔细胞癌:原发性、复发性和转移性疾病的管理。17例患者的临床病理研究。
Eur J Surg Oncol. 1989 Feb;15(1):1-9.
10
[Cervicofacial neuroendocrine Merkel cell carcinoma: radiotherapy].
Acta Otorhinolaryngol Ital. 1994 Nov-Dec;14(6):651-7.

引用本文的文献

1
Risk of second cancers in merkel cell carcinoma: a meta-analysis of population based cohort studies.默克尔细胞癌二次患癌风险:基于人群队列研究的荟萃分析
J Skin Cancer. 2014;2014:184245. doi: 10.1155/2014/184245. Epub 2014 Dec 10.
2
A practical update of surgical management of merkel cell carcinoma of the skin.皮肤默克尔细胞癌手术治疗的实用进展
ISRN Surg. 2013;2013:850797. doi: 10.1155/2013/850797. Epub 2013 Jan 30.
3
Merkel cell carcinoma: a systematic review of ENT presentations. Merkel 细胞癌:耳鼻喉表现的系统回顾。
Eur Arch Otorhinolaryngol. 2013 Aug;270(8):2191-9. doi: 10.1007/s00405-012-2283-1. Epub 2012 Nov 29.
4
A review of the epidemiology and treatment of Merkel cell carcinoma. Merkel 细胞癌的流行病学和治疗综述。
Clinics (Sao Paulo). 2011;66(10):1817-23. doi: 10.1590/s1807-59322011001000023.
5
Merkel cell carcinoma: correlation of KIT expression with survival and evaluation of KIT gene mutational status.默克尔细胞癌:KIT 表达与生存的相关性及其 KIT 基因突变状态的评估。
Hum Pathol. 2010 Oct;41(10):1405-12. doi: 10.1016/j.humpath.2010.02.010. Epub 2010 Jul 1.
6
Multimodality management for 145 cases of Merkel cell carcinoma.多模态管理 145 例 Merkel 细胞癌。
Med Oncol. 2010 Dec;27(4):1260-6. doi: 10.1007/s12032-009-9369-7. Epub 2009 Dec 1.
7
[Clinical aspects and therapy of Merkel cell tumor--report of 4 personal cases and review of the literature].默克尔细胞肿瘤的临床特征与治疗——4例个人病例报告及文献综述
Langenbecks Arch Chir. 1988;373(3):173-81. doi: 10.1007/BF01274230.